A Case of a Durable Partial Response to Late‐Line Axitinib Following Prior Use of Tyrosine Kinase Inhibitors in Metastatic Papillary Renal Cell Carcinoma

ABSTRACT Introduction Metastatic papillary renal cell carcinoma (PRCC) is associated with a poor prognosis. Many patients with PRCC respond to first‐ and second‐line systemic chemotherapy treatments; however, few respond to late‐sequence treatment. We describe a case of a long‐term response to fourt...

Descrición completa

Detalles Bibliográficos

Principais autores:	Naoto Hodotsuka, Yasutomo Suzuki, Shohei Yamaki, Yuichiro Honda, Kyota Suzuki, Shuma Endo, Eigo Kuribayashi, Yukihiro Kondo
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-01-01
Series:	IJU Case Reports
Assuntos:	axitinib computed tomography renal cell carcinoma tyrosine kinase inhibitor vascular endothelial growth factor
Acceso en liña:	https://doi.org/10.1002/iju5.70115
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!